伐昔洛韦治疗单纯疱疹脑炎。
Valacyclovir for herpes simplex encephalitis.
机构信息
Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
出版信息
Antimicrob Agents Chemother. 2011 Jul;55(7):3624-6. doi: 10.1128/AAC.01023-10. Epub 2011 May 16.
Abstract
The recommended treatment for herpes simplex encephalitis (HSE) remains intravenous acyclovir. In resource-poor countries, however, intravenous formulations are usually unavailable or unaffordable. We report the penetration of acyclovir into the cerebrospinal fluid (CSF) in patients with HSE, treated with the oral prodrug valacyclovir at 1,000 mg three times daily. The oral therapy achieved adequate acyclovir concentrations in the CSF and may be an acceptable early treatment for suspected HSE in resource-limited settings.
摘要
推荐用于单纯疱疹脑炎（HSE）的治疗方法仍然是静脉注射阿昔洛韦。然而，在资源匮乏的国家，静脉制剂通常无法获得或负担不起。我们报告了口服前药伐昔洛韦，每天三次，每次 1000 毫克，用于治疗 HSE 患者时，阿昔洛韦在脑脊液（CSF）中的渗透情况。这种口服治疗方法可使 CSF 中的阿昔洛韦浓度达到足够水平，在资源有限的情况下，可能是疑似 HSE 的一种可接受的早期治疗方法。
相似文献
1
Valacyclovir for herpes simplex encephalitis.伐昔洛韦治疗单纯疱疹脑炎。
Antimicrob Agents Chemother. 2011 Jul;55(7):3624-6. doi: 10.1128/AAC.01023-10. Epub 2011 May 16.
2
Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.口服伐昔洛韦后血清和脑脊液中的阿昔洛韦水平。
Antimicrob Agents Chemother. 2003 Aug;47(8):2438-41. doi: 10.1128/AAC.47.8.2438-2441.2003.
3
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.单纯疱疹性脑炎：长期使用伐昔洛韦治疗缺乏临床获益
Clin Infect Dis. 2015 Sep 1;61(5):683-91. doi: 10.1093/cid/civ369. Epub 2015 May 8.
4
Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.肾功能正常和受损受试者中给予高剂量伐昔洛韦后脑脊液和全身循环中阿昔洛韦及其代谢物的药代动力学。
Antimicrob Agents Chemother. 2010 Mar;54(3):1146-51. doi: 10.1128/AAC.00729-09. Epub 2009 Dec 28.
5
Multiple oral dosing of valacyclovir in horses and ponies.伐昔洛韦在马和矮种马中的多次口服给药。
J Vet Pharmacol Ther. 2009 Jun;32(3):207-12. doi: 10.1111/j.1365-2885.2008.01025.x.
6
A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.口服伐昔洛韦与阿昔洛韦治疗免疫功能正常的复发性生殖器疱疹感染患者的随机、安慰剂对照比较。伐昔洛韦国际研究小组。
Arch Dermatol. 1998 Feb;134(2):185-91. doi: 10.1001/archderm.134.2.185.
7
Editorial Commentary: Failure of Adjunctive Valacyclovir to Improve Outcomes in Herpes Simplex Encephalitis.
Clin Infect Dis. 2015 Sep 1;61(5):692-4. doi: 10.1093/cid/civ373. Epub 2015 May 8.
8
Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.盐酸伐昔洛韦（万乃洛韦）：一种阿昔洛韦前体药物，其药代动力学有所改善，治疗带状疱疹疗效更佳。
Adv Exp Med Biol. 1996;394:33-9. doi: 10.1007/978-1-4757-9209-6_4.
9
Pharmacology of new antiherpes agents: famciclovir and valacyclovir.新型抗疱疹药物的药理学：泛昔洛韦和伐昔洛韦。
J Am Pharm Assoc (Wash). 1997 Mar-Apr;NS37(2):157-63. doi: 10.1016/s1086-5802(16)30202-9.
10
A missed point in deciphering the viral synergy between herpes simplex virus and HIV.在解读单纯疱疹病毒与艾滋病毒之间的病毒协同作用时被忽略的一点。
Lancet Infect Dis. 2009 Sep;9(9):522-3. doi: 10.1016/S1473-3099(09)70209-9.
引用本文的文献
1
An Atypical Case of Varicella Meningitis in a Young Immunocompetent Male Patient With a Possible Concomitant Case of Ramsay-Hunt Syndrome.一名免疫功能正常的年轻男性患者患水痘性脑膜炎的非典型病例，可能合并拉姆齐-亨特综合征。
Cureus. 2025 Aug 3;17(8):e89299. doi: 10.7759/cureus.89299. eCollection 2025 Aug.
2
Revisiting Acyclovir Dosing for Adult Viral Encephalitis Using a Full Bayesian LeiCNS PBPK Modeling Approach.使用全贝叶斯LeiCNS PBPK建模方法重新审视成人病毒性脑炎的阿昔洛韦给药剂量
Clin Pharmacokinet. 2025 Jul 13. doi: 10.1007/s40262-025-01545-w.
3
Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model.阿昔洛韦在中枢神经系统各腔室中的分布：一种猪的药代动力学模型。
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0181124. doi: 10.1128/aac.01811-24. Epub 2025 Jul 9.
4
Pharmacological targeting of mitophagy via ALT001 improves herpes simplex virus 1 (HSV1)-mediated microglial inflammation and promotes amyloid β phagocytosis by restricting HSV1 infection.通过ALT001对线粒体自噬进行药理学靶向作用，可改善单纯疱疹病毒1（HSV1）介导的小胶质细胞炎症，并通过限制HSV1感染促进β淀粉样蛋白吞噬作用。
Theranostics. 2025 Mar 31;15(11):4890-4908. doi: 10.7150/thno.105953. eCollection 2025.
5
CNS Viral Infections-What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches.中枢神经系统病毒感染——改善药物治疗需要考虑的因素：呼吁采用数学建模方法。
CNS Drugs. 2024 May;38(5):349-373. doi: 10.1007/s40263-024-01082-3. Epub 2024 Apr 5.
6
Global Landscape of Encephalitis: Key Priorities to Reduce Future Disease Burden.全球脑炎形势：降低未来疾病负担的重点优先事项。
Clin Infect Dis. 2023 Nov 30;77(11):1552-1560. doi: 10.1093/cid/ciad417.
7
Detection of HSV-1, HSV-2 and VZV Isolated from Cerebrospinal Fluid Samples of Children Suspected to Encephalitis.从疑似脑炎儿童脑脊液样本中分离出的单纯疱疹病毒1型、单纯疱疹病毒2型和水痘-带状疱疹病毒的检测
Adv Biomed Res. 2023 May 30;12:141. doi: 10.4103/abr.abr_322_22. eCollection 2023.
8
Herpes simplex virus encephalitis: An atypical presentation of delirium.单纯疱疹病毒性脑炎：一种谵妄的非典型表现。
Clin Case Rep. 2023 Mar 26;11(3):e7123. doi: 10.1002/ccr3.7123. eCollection 2023 Mar.
9
Surveillance of Viral Encephalitis in the Context of COVID-19: A One-Year Observational Study among Hospitalized Patients in Dakar, Senegal.在 COVID-19 背景下对病毒性脑炎的监测：塞内加尔达喀尔住院患者的一年观察性研究。
Viruses. 2022 Apr 22;14(5):871. doi: 10.3390/v14050871.
10
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease.VALZ-先导研究：高剂量伐昔洛韦治疗早期阿尔茨海默病患者
Alzheimers Dement (N Y). 2022 Mar 14;8(1):e12264. doi: 10.1002/trc2.12264. eCollection 2022.
本文引用的文献
1
Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study.越南南部儿童脑炎的病毒病因：一项为期一年的前瞻性描述性研究结果。
PLoS Negl Trop Dis. 2010 Oct 26;4(10):e854. doi: 10.1371/journal.pntd.0000854.
2
Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.肾功能正常和受损受试者中给予高剂量伐昔洛韦后脑脊液和全身循环中阿昔洛韦及其代谢物的药代动力学。
Antimicrob Agents Chemother. 2010 Mar;54(3):1146-51. doi: 10.1128/AAC.00729-09. Epub 2009 Dec 28.
3
Acyclovir susceptibility of herpes simplex virus isolates at King Chulalongkorn Memorial Hospital, Bangkok.曼谷朱拉隆功国王纪念医院单纯疱疹病毒分离株的阿昔洛韦敏感性
J Med Assoc Thai. 2008 Jun;91(6):908-12.
4
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-2003. A 50-year-old Colombian man with fever and seizures.
N Engl J Med. 2003 Aug 21;349(8):789-96. doi: 10.1056/NEJMcpc030020.
5
Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.口服伐昔洛韦后血清和脑脊液中的阿昔洛韦水平。
Antimicrob Agents Chemother. 2003 Aug;47(8):2438-41. doi: 10.1128/AAC.47.8.2438-2441.2003.
6
Determination of acyclovir in plasma by solid-phase extraction and column liquid chromatography.通过固相萃取和柱液相色谱法测定血浆中的阿昔洛韦。
Ther Drug Monit. 1999 Feb;21(1):129-33. doi: 10.1097/00007691-199902000-00020.
7
Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography.采用固相萃取和高效液相色谱法测定血清和尿液中的阿昔洛韦及其代谢产物9-羧基甲氧基甲基鸟嘌呤。
J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):363-6. doi: 10.1016/s0378-4347(96)00424-0.
8
Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.阿昔洛韦的L-缬氨酸酯伐昔洛韦口服给药后在人体内的绝对生物利用度和代谢情况。
Antimicrob Agents Chemother. 1995 Dec;39(12):2759-64. doi: 10.1128/AAC.39.12.2759.
9
Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.阿昔洛韦前体药物伐昔洛韦在对正常志愿者进行单剂量和多剂量递增给药后的药代动力学。
Clin Pharmacol Ther. 1993 Dec;54(6):595-605. doi: 10.1038/clpt.1993.196.
10
Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.静脉注射后阿昔洛韦在人体内的药代动力学。一种肠外抗病毒药物研发模型。
Am J Med. 1982 Jul 20;73(1A):165-71. doi: 10.1016/0002-9343(82)90084-5.
Zotero 插件